| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 6.52e-06 | 43 | 123 | 5 | GO:0030280 | |
| GeneOntologyMolecularFunction | RNA polymerase III cis-regulatory region sequence-specific DNA binding | 7.84e-06 | 7 | 123 | 3 | GO:0000992 | |
| GeneOntologyMolecularFunction | RNA polymerase III transcription regulatory region sequence-specific DNA binding | 1.25e-05 | 8 | 123 | 3 | GO:0001016 | |
| GeneOntologyMolecularFunction | RNA polymerase III general transcription initiation factor activity | 6.24e-05 | 13 | 123 | 3 | GO:0000995 | |
| GeneOntologyMolecularFunction | 5S rDNA binding | 1.12e-04 | 3 | 123 | 2 | GO:0080084 | |
| GeneOntologyMolecularFunction | RNA polymerase III type 2 promoter sequence-specific DNA binding | 1.12e-04 | 3 | 123 | 2 | GO:0001003 | |
| GeneOntologyMolecularFunction | RNA polymerase III type 1 promoter sequence-specific DNA binding | 1.12e-04 | 3 | 123 | 2 | GO:0001002 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 4.19e-04 | 363 | 123 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 4.43e-04 | 446 | 123 | 10 | GO:0004674 | |
| GeneOntologyMolecularFunction | RNA polymerase III type 3 promoter sequence-specific DNA binding | 5.55e-04 | 6 | 123 | 2 | GO:0001006 | |
| GeneOntologyMolecularFunction | chromo shadow domain binding | 5.55e-04 | 6 | 123 | 2 | GO:0070087 | |
| GeneOntologyMolecularFunction | protein kinase activity | HJV IRAK2 HIPK3 CAMKK2 LATS2 MTOR ULK4 ATM PRKG1 MAP2K5 ULK2 | 1.21e-03 | 600 | 123 | 11 | GO:0004672 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.18e-08 | 75 | 119 | 8 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.07e-07 | 99 | 119 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.16e-07 | 100 | 119 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | skin development | KRT9 KRT14 KRT17 KRT81 ENPP1 KRT83 KRT84 KRT85 KRT86 DICER1 LATS2 SOS1 | 1.71e-06 | 373 | 119 | 12 | GO:0043588 |
| GeneOntologyBiologicalProcess | keratinization | 1.12e-05 | 87 | 119 | 6 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.41e-05 | 189 | 119 | 8 | GO:0030216 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 1.44e-05 | 249 | 119 | 9 | GO:0035264 | |
| GeneOntologyBiologicalProcess | molting cycle | 2.65e-05 | 150 | 119 | 7 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 2.65e-05 | 150 | 119 | 7 | GO:0042633 | |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase III | 3.16e-05 | 63 | 119 | 5 | GO:0006383 | |
| GeneOntologyBiologicalProcess | tRNA transcription by RNA polymerase III | 3.97e-05 | 12 | 119 | 3 | GO:0042797 | |
| GeneOntologyBiologicalProcess | tRNA transcription | 5.13e-05 | 13 | 119 | 3 | GO:0009304 | |
| GeneOntologyBiologicalProcess | epidermis development | KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 DICER1 LATS2 SOS1 | 7.44e-05 | 461 | 119 | 11 | GO:0008544 |
| GeneOntologyBiologicalProcess | post-embryonic forelimb morphogenesis | 9.86e-05 | 3 | 119 | 2 | GO:0035128 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 1.33e-04 | 135 | 119 | 6 | GO:0009791 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 1.43e-04 | 46 | 119 | 4 | GO:0009303 | |
| GeneOntologyBiologicalProcess | oligodendrocyte differentiation | 1.44e-04 | 137 | 119 | 6 | GO:0048709 | |
| GeneOntologyBiologicalProcess | developmental growth | OTOA ATRX ENPP1 SPG11 NCAPG2 DICER1 KMT2C SLC39A12 LATS2 MTOR ATM PRKG1 ULK2 NIPBL SOS1 | 2.40e-04 | 911 | 119 | 15 | GO:0048589 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 2.45e-04 | 284 | 119 | 8 | GO:0009913 | |
| GeneOntologyBiologicalProcess | growth | OTOA KRT17 ATRX ENPP1 SPG11 NCAPG2 DICER1 KMT2C SLC39A12 LATS2 PTPRJ MTOR ATM PRKG1 MAP2K5 ULK2 NIPBL SOS1 | 2.51e-04 | 1235 | 119 | 18 | GO:0040007 |
| GeneOntologyBiologicalProcess | post-embryonic limb morphogenesis | 3.26e-04 | 5 | 119 | 2 | GO:0035127 | |
| GeneOntologyBiologicalProcess | post-embryonic appendage morphogenesis | 3.26e-04 | 5 | 119 | 2 | GO:0035120 | |
| GeneOntologyBiologicalProcess | DNA repair | RNASEH2B ATRX RTEL1 USP44 MLH3 ABRAXAS1 KLHL15 TERB1 ATM ASCC3 NIPBL VCPIP1 | 3.70e-04 | 648 | 119 | 12 | GO:0006281 |
| GeneOntologyBiologicalProcess | walking behavior | 4.00e-04 | 60 | 119 | 4 | GO:0090659 | |
| GeneOntologyCellularComponent | keratin filament | 1.00e-07 | 97 | 122 | 8 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 5.69e-05 | 227 | 122 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT9 KRT14 KRT17 EFCAB6 KRT81 KRT83 KRT84 KRT85 KRT86 LRRC49 ARFGEF2 HOOK3 KIF15 DNAI2 CEP57 MX2 | 6.90e-05 | 899 | 122 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.58e-04 | 263 | 122 | 8 | GO:0045111 | |
| GeneOntologyCellularComponent | integrator complex | 2.39e-04 | 21 | 122 | 3 | GO:0032039 | |
| GeneOntologyCellularComponent | supramolecular fiber | CAB39 KRT9 KRT14 KRT17 EFCAB6 KRT81 KRT83 KRT84 KRT85 KRT86 LRRC49 ARFGEF2 HOOK3 KIF15 DNAI2 CEP57 MX2 | 4.95e-04 | 1179 | 122 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | transcription factor TFIIIC complex | 4.99e-04 | 6 | 122 | 2 | GO:0000127 | |
| GeneOntologyCellularComponent | supramolecular polymer | CAB39 KRT9 KRT14 KRT17 EFCAB6 KRT81 KRT83 KRT84 KRT85 KRT86 LRRC49 ARFGEF2 HOOK3 KIF15 DNAI2 CEP57 MX2 | 5.34e-04 | 1187 | 122 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | RNA polymerase III transcription regulator complex | 1.18e-03 | 9 | 122 | 2 | GO:0090576 | |
| HumanPheno | Perifollicular hyperkeratosis | 5.00e-06 | 4 | 56 | 3 | HP:0007468 | |
| HumanPheno | Abnormal perifollicular morphology | 2.46e-05 | 6 | 56 | 3 | HP:0031285 | |
| HumanPheno | Palmoplantar hyperkeratosis | 6.96e-05 | 129 | 56 | 8 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 7.76e-05 | 131 | 56 | 8 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 8.20e-05 | 132 | 56 | 8 | HP:0007556 | |
| HumanPheno | Abnormality of the plantar skin of foot | 8.53e-05 | 171 | 56 | 9 | HP:0100872 | |
| MousePheno | abnormal cell nucleus morphology | 5.61e-06 | 184 | 98 | 9 | MP:0003111 | |
| MousePheno | abnormal chromosome morphology | 2.87e-05 | 126 | 98 | 7 | MP:0003702 | |
| Domain | ARM-type_fold | IPO5 CAB39 IPO8 IPO7 ARMC3 UBR4 MROH5 ARFGEF2 PSMD1 NCAPG2 AP1B1 AP2B1 MTOR LTN1 TERB1 ULK4 ATM NIPBL TARBP1 | 6.49e-13 | 339 | 121 | 19 | IPR016024 |
| Domain | ARM-like | IPO5 CAB39 IPO8 IPO7 ARMC3 MROH5 ARFGEF2 PSMD1 NCAPG2 AP1B1 AP2B1 MTOR LTN1 TERB1 ULK4 NIPBL TARBP1 | 1.83e-12 | 270 | 121 | 17 | IPR011989 |
| Domain | - | IPO5 CAB39 IPO8 IPO7 ARMC3 MROH5 ARFGEF2 PSMD1 NCAPG2 AP1B1 AP2B1 MTOR TERB1 ULK4 NIPBL | 1.48e-11 | 222 | 121 | 15 | 1.25.10.10 |
| Domain | Intermediate_filament_CS | 7.06e-09 | 63 | 121 | 8 | IPR018039 | |
| Domain | Filament | 1.86e-08 | 71 | 121 | 8 | SM01391 | |
| Domain | IF | 2.08e-08 | 72 | 121 | 8 | PS00226 | |
| Domain | Filament | 2.32e-08 | 73 | 121 | 8 | PF00038 | |
| Domain | IF | 3.21e-08 | 76 | 121 | 8 | IPR001664 | |
| Domain | Keratin_2_head | 4.04e-07 | 24 | 121 | 5 | IPR032444 | |
| Domain | Keratin_2_head | 4.04e-07 | 24 | 121 | 5 | PF16208 | |
| Domain | Keratin_II | 6.20e-07 | 26 | 121 | 5 | IPR003054 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 4.16e-05 | 2 | 121 | 2 | IPR013037 | |
| Domain | - | 4.16e-05 | 2 | 121 | 2 | 2.60.40.1150 | |
| Domain | HEAT_REPEAT | 9.08e-05 | 70 | 121 | 5 | PS50077 | |
| Domain | IMPORTIN_B_NT | 9.16e-05 | 14 | 121 | 3 | PS50166 | |
| Domain | AP_complex_bsu_1_2_4 | 1.24e-04 | 3 | 121 | 2 | IPR016342 | |
| Domain | Cse1 | 1.24e-04 | 3 | 121 | 2 | PF08506 | |
| Domain | Cse1 | 1.24e-04 | 3 | 121 | 2 | IPR013713 | |
| Domain | B2-adapt-app_C | 1.24e-04 | 3 | 121 | 2 | PF09066 | |
| Domain | Importin-beta_N | 1.69e-04 | 17 | 121 | 3 | IPR001494 | |
| Domain | Keratin_I | 1.86e-04 | 44 | 121 | 4 | IPR002957 | |
| Domain | B2-adapt-app_C | 2.48e-04 | 4 | 121 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 2.48e-04 | 4 | 121 | 2 | IPR015151 | |
| Domain | AP_beta | 4.11e-04 | 5 | 121 | 2 | IPR026739 | |
| Domain | FATC | 4.11e-04 | 5 | 121 | 2 | PF02260 | |
| Domain | HEAT | 5.43e-04 | 58 | 121 | 4 | IPR000357 | |
| Domain | FAT | 6.14e-04 | 6 | 121 | 2 | PS51189 | |
| Domain | FATC | 6.14e-04 | 6 | 121 | 2 | PS51190 | |
| Domain | FAT | 6.14e-04 | 6 | 121 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 6.14e-04 | 6 | 121 | 2 | IPR003151 | |
| Domain | FATC_dom | 6.14e-04 | 6 | 121 | 2 | IPR003152 | |
| Domain | PIK_FAT | 6.14e-04 | 6 | 121 | 2 | IPR014009 | |
| Domain | Beta2_adaptin/TBP_C_dom | 6.14e-04 | 6 | 121 | 2 | IPR012295 | |
| Domain | FATC | 6.14e-04 | 6 | 121 | 2 | SM01343 | |
| Domain | - | 6.14e-04 | 6 | 121 | 2 | 3.30.310.10 | |
| Domain | Kinase-like_dom | IRAK2 HIPK3 CAMKK2 LATS2 MTOR ULK4 ATM PRKG1 MAP2K5 ULK2 SOS1 | 7.98e-04 | 542 | 121 | 11 | IPR011009 |
| Domain | Coatomer/calthrin_app_sub_C | 1.14e-03 | 8 | 121 | 2 | IPR009028 | |
| Domain | Alpha_adaptinC2 | 1.45e-03 | 9 | 121 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.45e-03 | 9 | 121 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.45e-03 | 9 | 121 | 2 | SM00809 | |
| Domain | ARM | 2.20e-03 | 40 | 121 | 3 | SM00185 | |
| Domain | PROTEIN_KINASE_ST | 2.48e-03 | 362 | 121 | 8 | PS00108 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.63e-03 | 12 | 121 | 2 | IPR013041 | |
| Domain | Pkinase | 3.39e-03 | 381 | 121 | 8 | PF00069 | |
| Domain | Armadillo | 3.49e-03 | 47 | 121 | 3 | IPR000225 | |
| Domain | Clathrin/coatomer_adapt-like_N | 4.14e-03 | 15 | 121 | 2 | IPR002553 | |
| Domain | PI3/4_kinase_CS | 4.14e-03 | 15 | 121 | 2 | IPR018936 | |
| Domain | Adaptin_N | 4.14e-03 | 15 | 121 | 2 | PF01602 | |
| Domain | IBN_N | 4.14e-03 | 15 | 121 | 2 | PF03810 | |
| Domain | - | 4.71e-03 | 16 | 121 | 2 | 1.10.1070.11 | |
| Domain | IBN_N | 4.71e-03 | 16 | 121 | 2 | SM00913 | |
| Domain | PI3Kc | 4.71e-03 | 16 | 121 | 2 | SM00146 | |
| Domain | PI3_PI4_kinase | 5.95e-03 | 18 | 121 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.95e-03 | 18 | 121 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.95e-03 | 18 | 121 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.95e-03 | 18 | 121 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.95e-03 | 18 | 121 | 2 | PS50290 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 7.13e-08 | 87 | 89 | 8 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.50e-06 | 129 | 89 | 8 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 5.38e-06 | 153 | 89 | 8 | MM15343 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION | 5.96e-05 | 34 | 89 | 4 | MM15435 | |
| Pathway | REACTOME_KERATINIZATION | 6.71e-05 | 217 | 89 | 8 | M27640 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION | 1.26e-04 | 41 | 89 | 4 | M739 | |
| Pubmed | 6.40e-11 | 63 | 123 | 8 | 16831889 | ||
| Pubmed | KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 UBR4 AP1B1 AP2B1 SOS1 | 2.12e-10 | 266 | 123 | 12 | 19380743 | |
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 3.96e-10 | 12 | 123 | 5 | 10692104 | |
| Pubmed | 1.14e-09 | 183 | 123 | 10 | 23956138 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | IPO5 CUL2 KIAA0930 IPO7 KRT17 KRT81 KRT84 KRT85 POLR2E USP25 PSMD1 DICER1 USP44 AP2B1 ABRAXAS1 KLHL15 ASCC3 TARBP1 VCPIP1 | 2.75e-09 | 1005 | 123 | 19 | 19615732 |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 4.32e-08 | 3 | 123 | 3 | 25557232 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 4.32e-08 | 3 | 123 | 3 | 1372089 | |
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 1712823 | ||
| Pubmed | Sequences and differential expression of three novel human type-II hair keratins. | 4.32e-08 | 3 | 123 | 3 | 9084137 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.68e-08 | 202 | 123 | 9 | 33005030 | |
| Pubmed | IPO5 ACAP1 KRT9 IPO7 LSG1 UBR4 ARFGEF2 PSMD1 ERGIC2 CCDC77 NCAPG2 KIF15 AP2B1 MTOR ENTPD1 EXOC2 ASCC3 EXOC4 | 1.63e-07 | 1168 | 123 | 18 | 19946888 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 9457912 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 15797458 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 9707615 | ||
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 2.62e-07 | 16 | 123 | 4 | 12399393 | |
| Pubmed | 5.54e-07 | 19 | 123 | 4 | 27234308 | ||
| Pubmed | IPO5 CUL2 TBC1D9B IPO8 IPO7 PPFIBP1 UBR4 POLR2E PSMD1 NCAPG2 DICER1 HOOK3 AP2B1 MTOR LTN1 ATM EXOC2 ASCC3 EXOC4 | 7.59e-07 | 1440 | 123 | 19 | 30833792 | |
| Pubmed | IPO5 CUL2 IPO7 PSMD1 GTF3C5 THOC5 AP1B1 AP2B1 INTS13 LTN1 EXOC2 EXOC4 | 7.69e-07 | 560 | 123 | 12 | 35241646 | |
| Pubmed | KRT14 KRT17 ATRX ARMC3 LSG1 KRT84 UBR4 SANBR PSMD1 SPG11 CCDC77 TNRC18 LATS2 AP2B1 ATM PLCH1 DTHD1 CEP57 NIPBL | 7.74e-07 | 1442 | 123 | 19 | 35575683 | |
| Pubmed | GCFC2 IPO8 PPFIBP1 UBR4 PSMD1 CCDC77 THOC5 WTAP KMT2C TNRC18 INTS15 POC5 TARBP1 | 1.08e-06 | 689 | 123 | 13 | 36543142 | |
| Pubmed | CUL2 IPO8 IPO7 ATRX LSG1 PPFIBP1 UBR4 SPG11 FASTKD2 CCDC77 NCAPG2 DICER1 GTF3C3 THOC5 CAMKK2 ATM ASCC3 PLCH1 EXOC4 | 1.22e-06 | 1487 | 123 | 19 | 33957083 | |
| Pubmed | 1.33e-06 | 222 | 123 | 8 | 37071664 | ||
| Pubmed | ATRX KRT81 UBR4 USP25 ARFGEF2 PSMD1 EPG5 HIPK3 RLF AP1B1 ASCC3 VCPIP1 | 1.35e-06 | 591 | 123 | 12 | 15231748 | |
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 11682607 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.98e-06 | 104 | 123 | 6 | 31240132 | |
| Pubmed | 2.39e-06 | 8 | 123 | 3 | 27114554 | ||
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 2.45e-06 | 27 | 123 | 4 | 23027611 | |
| Pubmed | LRRC49 UBR4 PSMD1 GTF3C5 GTF3C3 RLF KIF15 ASCC3 EXOC4 VCPIP1 | 2.53e-06 | 418 | 123 | 10 | 34709266 | |
| Pubmed | IPO5 IPO8 IPO7 UBR4 PSMD1 GTF3C5 GTF3C3 AP1B1 AP2B1 MTOR ASCC3 EXOC4 | 2.96e-06 | 638 | 123 | 12 | 33239621 | |
| Pubmed | IPO5 ATRX PPFIBP1 KRT83 UBR4 USP25 ARFGEF2 PSMD1 AP2B1 SH3D19 ATM RAPGEF2 NIPBL TARBP1 EXOC4 VCPIP1 SOS1 | 2.97e-06 | 1285 | 123 | 17 | 35914814 | |
| Pubmed | CUL2 SAMD9 ATRX LSG1 ENPP1 PPFIBP1 ERGIC2 NCAPG2 DICER1 AP1B1 PLCH1 EXOC4 | 3.58e-06 | 650 | 123 | 12 | 38777146 | |
| Pubmed | IPO5 IPO7 UBR4 PSMD1 DICER1 GTF3C3 AP1B1 AP2B1 MTOR ATM ASCC3 NIPBL | 3.75e-06 | 653 | 123 | 12 | 22586326 | |
| Pubmed | 3.75e-06 | 437 | 123 | 10 | 20562859 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IPO5 RNASEH2B CUL2 IPO7 KRT17 UBR4 POLR2E USP25 ARFGEF2 PSMD1 NIF3L1 UNC13D KIF15 AP1B1 AP2B1 MTOR INTS13 VCPIP1 | 3.77e-06 | 1455 | 123 | 18 | 22863883 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | IPO8 ATRX SZT2 LSG1 POTEG HIPK3 SLC39A12 AP1B1 ENTPD1 ULK4 IL17RD | 4.53e-06 | 552 | 123 | 11 | 10737800 |
| Pubmed | 4.95e-06 | 451 | 123 | 10 | 36168627 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TBC1D9B IPO7 UBR4 POLR2E PSMD1 NCAPG2 GTF3C3 AP1B1 MTOR B3GNT2 ASCC3 TARBP1 EXOC4 VCPIP1 | 6.52e-06 | 942 | 123 | 14 | 31073040 |
| Pubmed | 6.86e-06 | 197 | 123 | 7 | 23686814 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | IPO5 IPO7 ATRX ARFGEF2 PSMD1 AP1B1 INTS13 ATM EXOC2 NIPBL EXOC4 | 7.46e-06 | 582 | 123 | 11 | 20467437 |
| Pubmed | CUL2 UBR4 USP25 PSMD1 ERGIC2 KIF15 AP2B1 ABRAXAS1 ASCC3 VCPIP1 | 8.69e-06 | 481 | 123 | 10 | 28190767 | |
| Pubmed | 9.07e-06 | 288 | 123 | 8 | 23383273 | ||
| Pubmed | 9.28e-06 | 12 | 123 | 3 | 30515972 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | IPO5 CUL2 IPO8 IPO7 UBR4 PSMD1 NCAPG2 DICER1 AP1B1 AP2B1 MTOR LTN1 ASCC3 VCPIP1 | 9.49e-06 | 974 | 123 | 14 | 28675297 |
| Pubmed | KRT14 KRT17 PSMD1 HIPK3 KMT2C AP2B1 SH3D19 RAPGEF2 MAP2K5 SOS1 | 9.50e-06 | 486 | 123 | 10 | 20936779 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT9 KRT14 SAMD9 IPO7 KRT17 LSG1 PPFIBP1 KRT84 KRT85 POLR2E GTF3C5 GTF3C3 THOC5 WTAP AP2B1 ASCC3 | 9.65e-06 | 1257 | 123 | 16 | 36526897 |
| Pubmed | 9.85e-06 | 488 | 123 | 10 | 31324722 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | IPO5 KRT9 KRT14 IPO7 KRT17 LSG1 PPFIBP1 KRT85 UBR4 POLR2E PSMD1 AP1B1 AP2B1 EXOC2 NIPBL TARBP1 VCPIP1 | 1.05e-05 | 1415 | 123 | 17 | 28515276 |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 24168496 | ||
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 1.24e-05 | 2 | 123 | 2 | 15744029 | |
| Pubmed | Protein-altering germline mutations implicate novel genes related to lung cancer development. | 1.24e-05 | 2 | 123 | 2 | 32393777 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 29378238 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 2433272 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 9665406 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21937706 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 9402962 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 29675630 | ||
| Pubmed | Regulation of canonical transient receptor potential isoform 3 (TRPC3) channel by protein kinase G. | 1.24e-05 | 2 | 123 | 2 | 14983059 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22846899 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 20871598 | ||
| Pubmed | Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach. | 1.24e-05 | 2 | 123 | 2 | 30066921 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 29516286 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 1.26e-05 | 84 | 123 | 5 | 29563501 | |
| Pubmed | HJV IPO5 RNASEH2B CAB39 ATRX SZT2 UBR4 UNC13D SPG11 NCAPG2 DICER1 RLF KMT2C ULK2 NIPBL SOS1 | 1.88e-05 | 1327 | 123 | 16 | 32694731 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TBC1D9B IPO8 IPO7 UBR4 POLR2E PSMD1 AP1B1 MTOR LTN1 MX2 EXOC4 | 1.99e-05 | 647 | 123 | 11 | 26618866 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GCFC2 ATRX ARFGEF2 PSMD1 WTAP FAM13A ATM EXOC2 SNAPC4 NIPBL VCPIP1 SOS1 | 2.05e-05 | 774 | 123 | 12 | 15302935 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CAB39 ATRX PPFIBP1 POLR2E DICER1 HIPK3 CAMKK2 LATS2 AP1B1 AP2B1 PRKG1 MAP2K5 SOS1 | 2.15e-05 | 910 | 123 | 13 | 36736316 |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 2.33e-05 | 238 | 123 | 7 | 35864588 | |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 2.34e-05 | 16 | 123 | 3 | 15085952 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | IPO7 LSG1 UBR4 POLR2E PSMD1 FASTKD2 NCAPG2 GTF3C5 GTF3C3 RLF AP2B1 LTN1 EXOC2 ASCC3 NIPBL EXOC4 | 2.38e-05 | 1353 | 123 | 16 | 29467282 |
| Pubmed | 2.41e-05 | 96 | 123 | 5 | 23580065 | ||
| Pubmed | 2.57e-05 | 48 | 123 | 4 | 27703004 | ||
| Pubmed | Dlx3 is a crucial regulator of hair follicle differentiation and cycling. | 3.39e-05 | 18 | 123 | 3 | 18684741 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 23027865 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 17360756 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 24471966 | ||
| Pubmed | Characterization of the TRBP domain required for dicer interaction and function in RNA interference. | 3.71e-05 | 3 | 123 | 2 | 19422693 | |
| Pubmed | Protein kinase C can inhibit TRPC3 channels indirectly via stimulating protein kinase G. | 3.71e-05 | 3 | 123 | 2 | 16331690 | |
| Pubmed | Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex. | 3.71e-05 | 3 | 123 | 2 | 25439321 | |
| Pubmed | Sequence data and chromosomal localization of human type I and type II hair keratin genes. | 3.71e-05 | 3 | 123 | 2 | 7556444 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 22362778 | ||
| Pubmed | Preferential utilization of Imp7/8 in nuclear import of Smads. | 3.71e-05 | 3 | 123 | 2 | 18519565 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 12445204 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 21641396 | ||
| Pubmed | ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. | 3.71e-05 | 3 | 123 | 2 | 20160076 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KIAA0930 TBC1D9B SZT2 UBR4 ARFGEF2 PCNX2 KMT2C TNRC18 LATS2 MTOR ULK4 SNAPC4 IL17RD ULK2 | 3.81e-05 | 1105 | 123 | 14 | 35748872 |
| Pubmed | PERP regulates enamel formation via effects on cell-cell adhesion and gene expression. | 4.01e-05 | 19 | 123 | 3 | 21285247 | |
| Pubmed | 4.06e-05 | 107 | 123 | 5 | 32989256 | ||
| Pubmed | CUL2 UBR4 USP25 ERGIC2 NCAPG2 GTF3C3 AP2B1 ABRAXAS1 ASCC3 MAP2K5 | 6.00e-05 | 604 | 123 | 10 | 38803224 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 6.75e-05 | 119 | 123 | 5 | 35776542 | |
| Pubmed | KIAA0930 TBC1D9B RTEL1 PPFIBP1 THOC5 TNRC18 LTN1 PLCH1 EXOC4 | 6.78e-05 | 493 | 123 | 9 | 15368895 | |
| Pubmed | 7.13e-05 | 284 | 123 | 7 | 29459677 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IPO5 KRT14 IPO7 KRT17 KRT84 KRT86 POLR2E PSMD1 DICER1 GTF3C5 HOOK3 ASCC3 NIPBL | 7.17e-05 | 1024 | 123 | 13 | 24711643 |
| Pubmed | 7.41e-05 | 4 | 123 | 2 | 19885391 | ||
| Pubmed | 7.41e-05 | 4 | 123 | 2 | 26350970 | ||
| Pubmed | Transcriptional activation of a subset of hair keratin genes by the NF-kappaB effector p65/RelA. | 7.41e-05 | 4 | 123 | 2 | 18021261 | |
| Pubmed | The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone. | 7.41e-05 | 4 | 123 | 2 | 23832809 | |
| Pubmed | Elevated HMGN4 expression potentiates thyroid tumorigenesis. | 7.41e-05 | 4 | 123 | 2 | 28186538 | |
| Pubmed | ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins. | 7.41e-05 | 4 | 123 | 2 | 36346242 | |
| Pubmed | Salmonella-directed recruitment of new membrane to invasion foci via the host exocyst complex. | 7.41e-05 | 4 | 123 | 2 | 20579884 | |
| Pubmed | 7.41e-05 | 4 | 123 | 2 | 7534311 | ||
| Interaction | GPR17 interactions | TBC1D9B IPO8 PPFIBP1 ARFGEF2 SPG11 HOOK3 MTOR LTN1 ATM EXOC2 TARBP1 EXOC4 | 1.53e-07 | 283 | 122 | 12 | int:GPR17 |
| Interaction | COMTD1 interactions | CAB39 TBC1D9B IPO8 IPO7 PPFIBP1 NCAPG2 HOOK3 MTOR EXOC2 EXOC4 | 3.89e-07 | 200 | 122 | 10 | int:COMTD1 |
| Interaction | P2RY6 interactions | IPO5 TBC1D9B IPO8 IPO7 UBR4 POLR2E PSMD1 DICER1 PTPRJ MTOR LTN1 EXOC2 EXOC4 | 6.19e-07 | 385 | 122 | 13 | int:P2RY6 |
| Interaction | KRT19 interactions | KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 CCDC77 HOOK3 KIF15 EXOC4 | 1.18e-06 | 282 | 122 | 11 | int:KRT19 |
| Interaction | FPR1 interactions | 3.16e-06 | 147 | 122 | 8 | int:FPR1 | |
| Interaction | KRT16 interactions | 3.20e-06 | 197 | 122 | 9 | int:KRT16 | |
| Interaction | KRT27 interactions | 3.92e-06 | 202 | 122 | 9 | int:KRT27 | |
| Interaction | LRRC31 interactions | 4.43e-06 | 205 | 122 | 9 | int:LRRC31 | |
| Interaction | CFTR interactions | IPO5 CUL2 KRT9 TBC1D9B KRT14 IPO8 IPO7 KRT17 KRT81 KRT84 KRT85 KRT86 UBR4 POLR2E PSMD1 FASTKD2 AP1B1 AP2B1 MTOR ABRAXAS1 LTN1 PRKG1 MX2 EXOC4 | 7.69e-06 | 1480 | 122 | 24 | int:CFTR |
| Interaction | TNFSF13B interactions | 8.01e-06 | 119 | 122 | 7 | int:TNFSF13B | |
| Interaction | OFD1 interactions | IPO5 KRT81 KRT83 KRT86 POLR2E CCDC77 LATS2 AP2B1 POC5 SNAPC4 EXOC4 | 8.61e-06 | 347 | 122 | 11 | int:OFD1 |
| Interaction | KRT76 interactions | 1.20e-05 | 84 | 122 | 6 | int:KRT76 | |
| Interaction | PCM1 interactions | IPO5 KRT14 KRT81 KRT83 KRT86 LRRC49 CCDC77 HOOK3 LATS2 KIF15 POC5 EXOC4 | 1.31e-05 | 434 | 122 | 12 | int:PCM1 |
| Interaction | EFNA4 interactions | 1.52e-05 | 239 | 122 | 9 | int:EFNA4 | |
| Interaction | IQCB1 interactions | CAB39 KRT9 KRT14 IPO7 KRT17 ARFGEF2 IRAK2 LATS2 LTN1 SNAPC4 EXOC4 | 1.57e-05 | 370 | 122 | 11 | int:IQCB1 |
| Interaction | TRIM52 interactions | 1.66e-05 | 133 | 122 | 7 | int:TRIM52 | |
| Interaction | GPR182 interactions | IPO8 ARFGEF2 SPG11 ERGIC2 ACY1 NCAPG2 MTOR LTN1 ATM EXOC2 TARBP1 EXOC4 | 2.09e-05 | 455 | 122 | 12 | int:GPR182 |
| Interaction | KRT14 interactions | 2.24e-05 | 192 | 122 | 8 | int:KRT14 | |
| Interaction | VIM interactions | TBC1D9B KRT14 GCFC2 KRT17 KRT84 UBR4 TSGA10 PSMD1 NIF3L1 THOC5 WTAP CAMKK2 KIF15 B3GNT2 ASCC3 MAP2K5 | 2.81e-05 | 804 | 122 | 16 | int:VIM |
| Interaction | KRT37 interactions | 3.26e-05 | 100 | 122 | 6 | int:KRT37 | |
| Interaction | SLX4 interactions | IPO8 IPO7 ATRX RTEL1 CCDC77 NCAPG2 GTF3C5 GTF3C3 MLH3 AP1B1 AP2B1 ASCC3 NIPBL | 4.40e-05 | 572 | 122 | 13 | int:SLX4 |
| Interaction | DUXAP9 interactions | 4.58e-05 | 12 | 122 | 3 | int:DUXAP9 | |
| Interaction | VCP interactions | IPO5 CUL2 CAB39 KRT9 TBC1D9B KRT14 IPO7 KRT17 ATRX KRT81 PPFIBP1 UBR4 ARFGEF2 PSMD1 DICER1 GTF3C5 GTF3C3 AP1B1 AP2B1 MTOR ANXA10 VCPIP1 | 4.61e-05 | 1435 | 122 | 22 | int:VCP |
| Interaction | NPTN interactions | 4.98e-05 | 278 | 122 | 9 | int:NPTN | |
| Interaction | MTMR4 interactions | 5.02e-05 | 158 | 122 | 7 | int:MTMR4 | |
| Interaction | KRT25 interactions | 5.79e-05 | 35 | 122 | 4 | int:KRT25 | |
| Interaction | EPS15 interactions | 5.89e-05 | 220 | 122 | 8 | int:EPS15 | |
| Interaction | SIGLECL1 interactions | 6.48e-05 | 113 | 122 | 6 | int:SIGLECL1 | |
| Interaction | KRT13 interactions | 7.50e-05 | 116 | 122 | 6 | int:KRT13 | |
| Interaction | KRT8 interactions | KRT14 IPO8 KRT17 LSG1 KRT84 LRRC49 UBR4 CCDC77 KIF15 LTN1 CEP57 | 7.72e-05 | 441 | 122 | 11 | int:KRT8 |
| Interaction | KRT36 interactions | 8.64e-05 | 74 | 122 | 5 | int:KRT36 | |
| Interaction | ZUP1 interactions | 9.22e-05 | 174 | 122 | 7 | int:ZUP1 | |
| Interaction | KRT15 interactions | 1.06e-04 | 178 | 122 | 7 | int:KRT15 | |
| Interaction | GRB2 interactions | ACAP1 KRT9 KRT14 KRT17 KRT81 KRT83 KRT85 KRT86 UBR4 NIF3L1 HIPK3 PTPRJ AP2B1 SH3D19 SOS1 | 1.08e-04 | 806 | 122 | 15 | int:GRB2 |
| Interaction | DUSP2 interactions | 1.33e-04 | 81 | 122 | 5 | int:DUSP2 | |
| Interaction | CIB2 interactions | 1.33e-04 | 81 | 122 | 5 | int:CIB2 | |
| Interaction | PNKD interactions | 1.53e-04 | 132 | 122 | 6 | int:PNKD | |
| Interaction | CDX2 interactions | 1.76e-04 | 86 | 122 | 5 | int:CDX2 | |
| Interaction | SQSTM1 interactions | IPO5 CUL2 IPO7 ENPP1 NIF3L1 FASTKD2 CCDC77 GTF3C3 AP2B1 MTOR B3GNT2 DNAI2 ULK4 ASCC3 RAPGEF2 MAP2K5 ULK2 NIPBL EXOC4 | 1.95e-04 | 1257 | 122 | 19 | int:SQSTM1 |
| Interaction | LEFTY1 interactions | 2.16e-04 | 4 | 122 | 2 | int:LEFTY1 | |
| Interaction | IMPDH2 interactions | 2.40e-04 | 420 | 122 | 10 | int:IMPDH2 | |
| Interaction | TPGS2 interactions | 2.66e-04 | 21 | 122 | 3 | int:TPGS2 | |
| Interaction | KIR2DL4 interactions | 2.67e-04 | 94 | 122 | 5 | int:KIR2DL4 | |
| Interaction | CTDP1 interactions | 2.69e-04 | 207 | 122 | 7 | int:CTDP1 | |
| Interaction | OPALIN interactions | 2.85e-04 | 209 | 122 | 7 | int:OPALIN | |
| Interaction | IFFO1 interactions | 3.20e-04 | 54 | 122 | 4 | int:IFFO1 | |
| Interaction | NICN1 interactions | 3.51e-04 | 23 | 122 | 3 | int:NICN1 | |
| Interaction | H3C1 interactions | IPO5 RNASEH2B ATRX CDIN1 UBR4 GTF3C5 GTF3C3 RLF KMT2C TNRC18 PIEZO2 AP2B1 ATM NIPBL TARBP1 | 3.59e-04 | 901 | 122 | 15 | int:H3C1 |
| Interaction | SSX2IP interactions | 3.72e-04 | 288 | 122 | 8 | int:SSX2IP | |
| Interaction | C9orf78 interactions | IPO5 CUL2 IPO7 PSMD1 GTF3C5 THOC5 AP1B1 AP2B1 INTS13 LTN1 EXOC2 EXOC4 | 3.85e-04 | 620 | 122 | 12 | int:C9orf78 |
| Interaction | UBC interactions | CUL2 UBR4 USP25 PSMD1 USP44 KIF15 AP2B1 ABRAXAS1 ASCC3 VCPIP1 | 3.86e-04 | 446 | 122 | 10 | int:UBC |
| Interaction | SASS6 interactions | 4.18e-04 | 159 | 122 | 6 | int:SASS6 | |
| Interaction | HTR6 interactions | 4.21e-04 | 58 | 122 | 4 | int:HTR6 | |
| Interaction | KRT6A interactions | 4.32e-04 | 160 | 122 | 6 | int:KRT6A | |
| Interaction | KRT39 interactions | 4.50e-04 | 59 | 122 | 4 | int:KRT39 | |
| Interaction | BSG interactions | IPO5 GCFC2 IPO8 IPO7 ARFGEF2 NCAPG2 AP2B1 MTOR ATM EXOC2 TARBP1 EXOC4 | 4.51e-04 | 631 | 122 | 12 | int:BSG |
| Interaction | CEP128 interactions | 4.57e-04 | 297 | 122 | 8 | int:CEP128 | |
| Interaction | GPR45 interactions | 4.88e-04 | 300 | 122 | 8 | int:GPR45 | |
| Cytoband | 12q13 | 1.44e-06 | 71 | 123 | 5 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p11 | 8.40e-05 | 85 | 123 | 4 | chr12p11 | |
| GeneFamily | Keratins, type II | 8.62e-08 | 27 | 76 | 5 | 609 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.15e-05 | 11 | 76 | 3 | 1168 | |
| GeneFamily | Armadillo repeat containing|Importins | 5.57e-05 | 18 | 76 | 3 | 596 | |
| GeneFamily | Keratins, type I | 2.17e-04 | 28 | 76 | 3 | 608 | |
| GeneFamily | Exocyst complex | 6.16e-04 | 9 | 76 | 2 | 1055 | |
| GeneFamily | DNA helicases | 2.28e-03 | 17 | 76 | 2 | 1167 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | GCFC2 IPO8 IPO7 ATRX RTEL1 LRRC49 SANBR TSGA10 ARFGEF2 CCDC77 DICER1 HOOK3 KIF15 INTS13 CCBE1 ABRAXAS1 ATM RAPGEF2 CEP57 NIPBL SOS1 | 5.37e-06 | 1257 | 118 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CAB39 IPO7 EFCAB6 ATRX CDIN1 USP25 FASTKD2 RLF KIF15 RAPGEF2 CEP57 NIPBL | 1.20e-05 | 469 | 118 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | GCFC2 IPO8 IPO7 ATRX RTEL1 LRRC49 SANBR TSGA10 ARFGEF2 CCDC77 DICER1 HOOK3 KIF15 INTS13 CCBE1 ABRAXAS1 ATM RAPGEF2 CEP57 NIPBL SOS1 | 4.99e-05 | 1459 | 118 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-08 | 104 | 123 | 7 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.06e-07 | 187 | 123 | 7 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.12e-06 | 193 | 123 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 193 | 123 | 7 | afdf92ecace145407d57192dde5d0dac0bc37ee9 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-06 | 194 | 123 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 194 | 123 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-06 | 200 | 123 | 7 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-06 | 165 | 123 | 6 | 475905d608fac628960188ae4a18010b8097417e | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-06 | 165 | 123 | 6 | 622aca1d49bd8c917b131e4f4959d9dba411d22b | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 167 | 123 | 6 | 3c06894fc6177f3c204094719904da42f08b9af8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.59e-06 | 169 | 123 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.09e-05 | 105 | 123 | 5 | c7528276fee8f6d2cb4639069bc87413b0288025 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.09e-05 | 105 | 123 | 5 | 7bcf3345a21a1ade717128be127e9fe12ae40011 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.09e-05 | 105 | 123 | 5 | 62e89b92bb8c5187ab0205aebd018b4178710bb0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 187 | 123 | 6 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.39e-05 | 188 | 123 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 189 | 123 | 6 | 7ee9b00a8bd46f2da9218623bb2617b2e585f9d5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.43e-05 | 189 | 123 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 192 | 123 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 196 | 123 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-05 | 197 | 123 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.87e-05 | 198 | 123 | 6 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 199 | 123 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.97e-05 | 200 | 123 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.97e-05 | 200 | 123 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | (08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint | 4.68e-05 | 142 | 123 | 5 | e95d34170f5053678e0dd9793e68d93c03b05822 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-valve_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-05 | 153 | 123 | 5 | 1440f2716fea74e2c3eb2924eba3d63ebd08c997 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-05 | 154 | 123 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-05 | 154 | 123 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-05 | 155 | 123 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-05 | 155 | 123 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.73e-05 | 162 | 123 | 5 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.73e-05 | 162 | 123 | 5 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | 390C-Lymphocytic-ILC|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.25e-05 | 164 | 123 | 5 | b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.52e-05 | 165 | 123 | 5 | 7978eefcfc40175e933f7a8b64a5dd1c661dd1ac | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 9.79e-05 | 166 | 123 | 5 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | Ionocyte-iono-3|World / Class top | 9.79e-05 | 166 | 123 | 5 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 1.01e-04 | 167 | 123 | 5 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Lung / Manually curated celltypes from each tissue | 1.01e-04 | 167 | 123 | 5 | dcbcc658082910838c8082d71a64917055086cc4 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.04e-04 | 168 | 123 | 5 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 1.06e-04 | 169 | 123 | 5 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 171 | 123 | 5 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 171 | 123 | 5 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.16e-04 | 172 | 123 | 5 | 980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 174 | 123 | 5 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.22e-04 | 174 | 123 | 5 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 174 | 123 | 5 | c0204a0d0a979a489e8d30dc5396e99da14c119c | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.25e-04 | 175 | 123 | 5 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-04 | 177 | 123 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-04 | 177 | 123 | 5 | 2dd6dd5193bda9ba1c6b299ec47890fdc92f88b1 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 177 | 123 | 5 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 178 | 123 | 5 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 1.39e-04 | 179 | 123 | 5 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 180 | 123 | 5 | ca7c316027e31559103b2cab1a2c0de993e42e95 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 180 | 123 | 5 | eb26ba86fba26899e54c448afc25382ddc853013 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-04 | 182 | 123 | 5 | feda21c92d30848de70c8b404eaabbca3f5e894d | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 182 | 123 | 5 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 183 | 123 | 5 | d4a558bc0b8e11be195a7da1468ab38eb477117d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 184 | 123 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 184 | 123 | 5 | 2c2125b8030af83f7a6d59a7102d4de8e0ac1988 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 184 | 123 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 184 | 123 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 185 | 123 | 5 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.63e-04 | 185 | 123 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 185 | 123 | 5 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 185 | 123 | 5 | e1fd66f4295056807aa29c0e4ce6b1a79cc8dfcf | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.67e-04 | 186 | 123 | 5 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.71e-04 | 187 | 123 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-04 | 187 | 123 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 189 | 123 | 5 | 5c85656f555d91ecc9540faa67717694a4aef92f | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 190 | 123 | 5 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-04 | 190 | 123 | 5 | af39d2a46d9502cec69a69b7e8ffef78fc8311c3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-04 | 191 | 123 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-04 | 191 | 123 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-04 | 191 | 123 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 192 | 123 | 5 | 45ff9555f9a9fccc650885956005b2e5b4820a56 | |
| ToppCell | droplet-Tongue-Unstain|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 192 | 123 | 5 | 0f0fae7e1177609eff82fa4452042306297a7103 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.93e-04 | 192 | 123 | 5 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | droplet-Tongue-Unstain-18m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 192 | 123 | 5 | b198e42a962c4e24ea9faad867ca1255316a5d99 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.93e-04 | 192 | 123 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 192 | 123 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.98e-04 | 193 | 123 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.98e-04 | 193 | 123 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.98e-04 | 193 | 123 | 5 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.98e-04 | 193 | 123 | 5 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.98e-04 | 193 | 123 | 5 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.03e-04 | 194 | 123 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-04 | 194 | 123 | 5 | 5031f324628ff12a33e84cc52157be4786e0961d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.03e-04 | 194 | 123 | 5 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.03e-04 | 194 | 123 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.03e-04 | 194 | 123 | 5 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.07e-04 | 195 | 123 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.07e-04 | 195 | 123 | 5 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.07e-04 | 195 | 123 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.07e-04 | 195 | 123 | 5 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-04 | 195 | 123 | 5 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | Severe-NK|Severe / Disease group and Cell class | 2.12e-04 | 196 | 123 | 5 | 66130d38b67e51e2385de8a89227759fd137999c | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 2.12e-04 | 196 | 123 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | Severe-NK|World / Disease group and Cell class | 2.18e-04 | 197 | 123 | 5 | 1e5fb79385657a467c2d9f942d8cafb8ef7826c9 | |
| Computational | Genes in the cancer module 68. | 2.09e-05 | 26 | 69 | 4 | MODULE_68 | |
| Computational | Keratin. | 2.09e-05 | 26 | 69 | 4 | MODULE_298 | |
| Drug | al-Badry | 2.88e-07 | 165 | 123 | 9 | CID000004545 | |
| Drug | teleocidin B | 3.54e-07 | 123 | 123 | 8 | CID000072425 | |
| Drug | sulfur mustard | 5.40e-07 | 130 | 123 | 8 | CID000010461 | |
| Drug | homocysteine thiolactone | 5.73e-07 | 131 | 123 | 8 | CID000107712 | |
| Drug | pyriproxyfen | 6.63e-06 | 23 | 123 | 4 | CID000091753 | |
| Drug | AC1L9MJT | 9.95e-06 | 192 | 123 | 8 | CID000448959 | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; HL60; HT_HG-U133A | 1.16e-05 | 196 | 123 | 8 | 1338_UP | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; HL60; HT_HG-U133A | 1.16e-05 | 196 | 123 | 8 | 3093_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 1.16e-05 | 196 | 123 | 8 | 6471_DN | |
| Drug | 1-2q | 2.81e-05 | 289 | 123 | 9 | CID000011820 | |
| Drug | melicopicine | 2.89e-05 | 2 | 123 | 2 | CID000101253 | |
| Drug | tebuquine | 2.89e-05 | 2 | 123 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 2.89e-05 | 2 | 123 | 2 | CID000460896 | |
| Drug | Velcade (bortezomib | 3.67e-05 | 374 | 123 | 10 | CID000093860 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; HL60; HT_HG-U133A | 4.72e-05 | 175 | 123 | 7 | 2485_UP | |
| Drug | Hb 7 | 5.36e-05 | 14 | 123 | 3 | CID000128180 | |
| Drug | CP-9 | 6.68e-05 | 15 | 123 | 3 | CID000452634 | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 8.19e-05 | 191 | 123 | 7 | 6020_DN | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | 8.47e-05 | 192 | 123 | 7 | 1365_DN | |
| Drug | sulfonamide-3 | 8.65e-05 | 3 | 123 | 2 | CID009847197 | |
| Drug | tulipanin | 8.65e-05 | 3 | 123 | 2 | CID000192918 | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 9.03e-05 | 194 | 123 | 7 | 4171_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | 9.03e-05 | 194 | 123 | 7 | 4572_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 9.33e-05 | 195 | 123 | 7 | 3321_UP | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 6559_UP | |
| Drug | Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 7310_UP | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 7251_UP | |
| Drug | UTP-NA | ENPP1 POLR2E ADCY2 GTF3C5 GTF3C3 CAMKK2 ENTPD1 SNAPC4 PLCH1 MAP2K5 | 9.64e-05 | 420 | 123 | 10 | CID000001181 |
| Drug | CQ-S | 9.90e-05 | 17 | 123 | 3 | CID000072462 | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 3446_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 2362_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 2623_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; HL60; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 2966_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; PC3; HG-U133A | 1.06e-04 | 199 | 123 | 7 | 1915_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 7129_DN | |
| Drug | Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 2127_UP | |
| Drug | ATBI | 1.18e-04 | 18 | 123 | 3 | CID000505862 | |
| Disease | MONILETHRIX | 6.73e-08 | 3 | 121 | 3 | 158000 | |
| Disease | Beaded hair | 6.73e-08 | 3 | 121 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 6.73e-08 | 3 | 121 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 2.68e-07 | 4 | 121 | 3 | C0546966 | |
| Disease | Malignant neoplasm of breast | NPBWR1 ACAP1 TBC1D9B KRT14 UBR4 ARFGEF2 ACY1 ITGA9 THOC5 EPG5 SLC39A12 HOOK3 MTOR ABRAXAS1 ATM NIPBL | 8.44e-06 | 1074 | 121 | 16 | C0006142 |
| Disease | Intellectual Disability | RNASEH2B ACY1 GTF3C3 KMT2C AP1B1 MTOR CCBE1 KLHL15 ENTPD1 ASCC3 | 1.63e-05 | 447 | 121 | 10 | C3714756 |
| Disease | hair disease (is_implicated_in) | 1.67e-05 | 2 | 121 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 6.21e-05 | 19 | 121 | 3 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 6.21e-05 | 19 | 121 | 3 | C2936783 | |
| Disease | cancer (implicated_via_orthology) | 1.23e-04 | 268 | 121 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | aggressive behavior | 1.45e-04 | 25 | 121 | 3 | EFO_0003015 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.63e-04 | 26 | 121 | 3 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.83e-04 | 27 | 121 | 3 | C1112155 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.04e-04 | 28 | 121 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 2.27e-04 | 29 | 121 | 3 | C1333990 | |
| Disease | female breast cancer (is_implicated_in) | 4.59e-04 | 8 | 121 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | nevus count, cutaneous melanoma | 5.46e-04 | 91 | 121 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | Adenoid Cystic Carcinoma | 7.79e-04 | 100 | 121 | 4 | C0010606 | |
| Disease | brain volume measurement | 7.93e-04 | 595 | 121 | 9 | EFO_0006930 | |
| Disease | Hamman-Rich syndrome | 1.47e-03 | 14 | 121 | 2 | C0085786 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 1.47e-03 | 14 | 121 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | cutaneous melanoma | 1.58e-03 | 121 | 121 | 4 | EFO_0000389 | |
| Disease | colorectal cancer (is_implicated_in) | 1.58e-03 | 121 | 121 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.63e-03 | 206 | 121 | 5 | C0152013 | |
| Disease | idiopathic pulmonary fibrosis | 1.67e-03 | 57 | 121 | 3 | EFO_0000768 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.69e-03 | 15 | 121 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.69e-03 | 15 | 121 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.69e-03 | 15 | 121 | 2 | C0154091 | |
| Disease | Keratoderma, Palmoplantar | 1.93e-03 | 16 | 121 | 2 | C4551675 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.93e-03 | 16 | 121 | 2 | C0334634 | |
| Disease | Carcinoma of bladder | 2.44e-03 | 18 | 121 | 2 | C0699885 | |
| Disease | ascending aortic diameter | 2.69e-03 | 140 | 121 | 4 | EFO_0021787 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 2.72e-03 | 19 | 121 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | diet measurement, HOMA-B | 2.72e-03 | 19 | 121 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Usual Interstitial Pneumonia | 2.72e-03 | 19 | 121 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.72e-03 | 19 | 121 | 2 | C4721508 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 3.02e-03 | 20 | 121 | 2 | C4721952 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.28e-03 | 148 | 121 | 4 | C0279702 | |
| Disease | advanced glycosylation end product-specific receptor ligand measurement | 3.33e-03 | 21 | 121 | 2 | EFO_0010762 | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.33e-03 | 21 | 121 | 2 | C1800706 | |
| Disease | hair colour measurement | 3.91e-03 | 615 | 121 | 8 | EFO_0007822 | |
| Disease | Immunologic Deficiency Syndromes | 3.99e-03 | 23 | 121 | 2 | C0021051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NEMYASLQEELKSIC | 216 | Q6UWZ7 | |
| AFQLMQEDCIQKLLY | 1176 | Q9HCE0 | |
| EKMINTLILNYCQCL | 226 | Q9NZN9 | |
| QMILCNKSYQQLRLV | 196 | Q9UJ72 | |
| NCMQTDNLELKKLVY | 56 | P63010 | |
| QVLLDAEYKQMQCDF | 296 | Q96M83 | |
| INIDITVAMKCQYVG | 76 | Q96RQ1 | |
| EMFINAIKQYLCVAL | 426 | Q9Y6D5 | |
| AENKCNLLEKQLEYM | 136 | Q86XR8 | |
| EKKLSNMYQEQCISL | 356 | Q9BR77 | |
| TVEYICTQQNILFML | 116 | Q9Y376 | |
| KLMCELGNVIINQIY | 471 | Q15027 | |
| NCMQTDNLELKKLVY | 56 | Q10567 | |
| VKKNSMECIYNLVQD | 166 | Q5W041 | |
| YMICQSLISVLEEQI | 526 | Q96M86 | |
| QVLIMTCYVALNVLK | 146 | Q9UPY3 | |
| IMEHCIKQNNAIDIY | 116 | Q9GZS0 | |
| NMQECIDQKVYQAEV | 226 | Q6ZVN8 | |
| LMQIQKCELVLIHTY | 196 | Q9NVM9 | |
| VLNCQKTIYNLVDME | 491 | Q9NVM9 | |
| ELQLLEIMCNYFQEQ | 71 | Q96N11 | |
| VKVLCLNYNHIESIM | 1141 | Q6ZRR7 | |
| CEILQKMNITYDNLR | 1051 | O94822 | |
| DEELNALQSYCTMKI | 116 | Q96LL4 | |
| DATVAQVLLYQMIKC | 356 | Q7RTW8 | |
| VCIQISNDYEAKVAM | 311 | Q8NA72 | |
| NVYAIIMLTKCVEQG | 1131 | Q12913 | |
| QAKQDMARQLCEYQE | 436 | Q9NSB2 | |
| LIEDYRIKQQQQCAM | 3261 | Q8NEZ4 | |
| LFTVMCRKKQQENIY | 316 | Q8NFM7 | |
| ACLQDSYDNLQEIMK | 861 | Q9NS87 | |
| CYVKEMDANKENVIL | 196 | Q9H089 | |
| VENVMAKEICQKYLE | 446 | O43187 | |
| ECQNQEYSLLLSIKM | 431 | P35527 | |
| LCEAEQEQMRKILYQ | 636 | Q9NRM7 | |
| LNMDCIIAEIKAQYD | 286 | P78386 | |
| QCLNRYKKMQDTVVL | 331 | Q86W92 | |
| TEMLKQEEYQIQQNC | 71 | Q96IM9 | |
| QLRCEMEQQNQEYKI | 386 | P02533 | |
| NLELSQIQEIVDCMY | 106 | Q13976 | |
| QKAKQDMACLIREYQ | 376 | O43790 | |
| LNLILQKLDYMVTCA | 106 | Q6ICG6 | |
| ELYQQLNDLEACVMQ | 111 | P01562 | |
| QINTFCTYLLEQIDM | 971 | A6NKB5 | |
| NIMQVFIYCLEQLST | 661 | Q96KP1 | |
| DDLTNVIQKMICEYS | 556 | O95373 | |
| VLQQVDNKFIACLMS | 1191 | Q9UHC1 | |
| QKQIMSELEILYKCD | 206 | Q13163 | |
| QMLKLACSYEFINEI | 181 | Q9UGF5 | |
| YIQMVTALVLQLIQC | 1486 | Q6KC79 | |
| IEIRNKNSYMKLCLQ | 666 | Q8IUZ0 | |
| NIEVYNLMCDLLNLT | 566 | P22413 | |
| MTYIKCARNEQEQNL | 161 | Q9H4Q4 | |
| QKVNEIGIYLTDCME | 96 | P49961 | |
| AVNCEQKQEYIQAIM | 126 | Q86VS8 | |
| QQHYLDVIKRMLVQC | 166 | O00410 | |
| CNKIMAKILENYNTL | 216 | O94988 | |
| DYQLVQHEVLCSMKN | 181 | Q9H422 | |
| QVTEKLQLTYMEETC | 541 | Q13797 | |
| SDQFLNMVCVKLQEY | 601 | Q96A65 | |
| KCQELLNYIMDTVKD | 116 | Q13315 | |
| LMELALQQTYQDTCN | 211 | Q08462 | |
| YNDVLTKQQMLISCV | 2391 | P46100 | |
| QAAMYVQLIEVVKFC | 106 | Q96M94 | |
| LRCEMEQQNQEYKIL | 356 | Q04695 | |
| MKIYVENLIDCLNEK | 326 | P16383 | |
| TNYISICKMQEVLEE | 981 | Q5THR3 | |
| MILTKAQYDEIAQCL | 1 | Q9Y2V0 | |
| TCKEFYQMKQTVLQL | 201 | Q6UXH8 | |
| RIMEFIKENCYQVLT | 201 | P0DJR0 | |
| LLQESNCSQYMEKVL | 226 | Q13617 | |
| YRDIMVKVCDINLQS | 251 | Q6ZMT9 | |
| MQDCVQLNQYTLKDE | 156 | Q96RR4 | |
| EMQECTTQIQYLKQV | 86 | Q15007 | |
| QILDSRQVCVQYMKD | 71 | Q86YT5 | |
| YIIHQEEICSSKLNM | 121 | Q504Y0 | |
| QKAKQDMACLIREYQ | 381 | P78385 | |
| ELMCKLIVAIDQYNT | 106 | P48145 | |
| ELYQQLNDLEACVMQ | 111 | P05013 | |
| NDDVTNVIQKMICEY | 556 | O15397 | |
| NVIQKMICEYSQEVA | 561 | O15397 | |
| MEEITQQQLVHDKYC | 286 | P42345 | |
| QLCSFQVIKDIMQQL | 716 | Q6ZUA9 | |
| QLKVSNEEYACMKAI | 381 | Q15406 | |
| QQEYMTKVLECLQQK | 21 | Q9NZ71 | |
| CLFEDKVATMLQQQY | 191 | Q5T011 | |
| TIKVYCQRMQEENIT | 86 | P19388 | |
| VLVMLKQTENNYLEC | 441 | Q5HYK7 | |
| TMKCIVNEYTFLLEQ | 1361 | Q5K651 | |
| IMINILQSCKDLQYH | 381 | Q9NYY8 | |
| LVKEDNLLMAYQICF | 236 | Q99460 | |
| LNCTQKALMQVVDFL | 211 | Q9GZT8 | |
| EFLKMDSLVEQCIQY | 236 | Q6NSI8 | |
| QYVEELILQLLNMLC | 46 | Q07889 | |
| MSLEQDNIKQAIFCY | 226 | Q9Y5Q9 | |
| KMNQEQFIELCKTLY | 1021 | Q66K14 | |
| KNKNNICSYVDLMLV | 361 | Q9NY97 | |
| AQDMKCVSIQYLEAV | 111 | Q03154 | |
| QLNNMDEVCYENVLK | 696 | Q8N3C0 | |
| MQVICQSQLEIYKTI | 246 | Q8NCG5 | |
| IKDMLLECFININYI | 206 | Q86XI2 | |
| LKLMLQQCKTQYELG | 1606 | Q96JI7 | |
| YCRILNQVEKNMQKV | 231 | Q9Y4G8 | |
| CLVVGLEQYEQMLKT | 2921 | O15417 | |
| LEQQMENLVVCVKYG | 1581 | Q13129 | |
| YLFNMCLQQLFEVKV | 51 | Q5TBB1 | |
| CVIIVCKMLYQLQTI | 991 | Q9H5I5 | |
| CLMYINDKAQFLIQE | 651 | Q9UHP3 | |
| QEQAEKEMYSLCLLA | 886 | Q96JH7 | |
| MNNVTTDYCLDIIKK | 246 | Q4KWH8 | |
| YELQLTQEKIMCLDE | 226 | Q9BZW7 | |
| AEKLIYNCAVEMVQS | 961 | Q8IYT8 | |
| CLQLNMVYQEVIQEK | 86 | Q5SXM2 | |
| MFYQLCDLNVEELQK | 406 | Q9Y5Q8 | |
| QCYLLQTAMNLLDVE | 531 | Q13395 | |
| KYTCQELQRLMAEIQ | 56 | Q13769 | |
| TIVQKCLEIYDMIGQ | 376 | Q5T4S7 | |
| NVICQLLSDYKEKQM | 351 | Q6S5H5 | |
| LNLLLECLKYQMDNA | 16 | Q8NA31 | |
| KFLEVELCYMNTNLV | 796 | Q70J99 | |
| VTDTVVYQMNECQEK | 326 | Q9H0E7 | |
| MLEESKTLNVNCVDY | 46 | Q13507 | |
| LVACKDSNMELLYEQ | 1061 | Q96C45 | |
| KMESYLKQQQLCDVI | 201 | Q9NR64 | |
| QKAKQDMACLIREYQ | 376 | Q14533 | |
| QMVFCQDQIYSVVLK | 576 | P20592 |